Google Scholar publications link (up to date): https://scholar.google.com/citations?hl=en&user=9v-2F2EAAAAJ&view_op=list_works&sortby=pubdateCDR K. Scott Phillips, USPHS, is a Lab Chief for the Laboratory of Analytical Chemistry in the FDA Center for Biologics Evaluation and Research (CBER). Prior to his new role, he was a Lead Reviewer in the Center for Devices and Radiological Health (CDRH) OHT6 (Orthopedics) and a long-term Research Leader in the Laboratory of Microbiology and Infection Control, in the Division of Biology, Chemistry and Materials Science in CDRH. He is a recognized expert in the field of regulatory science, analytical chemistry, medical device biofilms and antimicrobial device technologies. He developed the first performance testing strategy rubric for antimicrobial devices (Nature Reviews Biomedical Engineering 2023) and pioneered the concept of Medical Devices on Chips (Guan et al. Nature Biomedical Engineering 2017, 1, 0045). He was the PI of a 3-hospital study of tje cleanliness of endoscopes at the point of reprocessing (manuscript in preparation), and Co-PI on several projects studying biofilm-associated infections. He has led projects involving collaboration with industry and academia, including negotiation and development of multi-party collaborative agreements needed to do groundbreaking research. He has supervised 29 students and postdocs at FDA, and has over 50 publications, several book chapters and one patent. In 2014, he co-organized a workshop at FDA on Medical Device Biofilms which was attended by over 430 people. He has numerous recent peer-reviewed papers on bacteria-material interactions and biofouling, and has provided over 350 consults in the past 8 years on antimicrobial medical device technology, chemistry and mechanism of action to CDRH reviewers. He is also an active contributor to the ISO TC-150 standard development for performance testing of antimicrobial devices.